# Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma

> **NCT04062877** · — · COMPLETED · sponsor: **Ge Zheng** · enrollment: 60 (actual)

## Conditions studied

- Lymphoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04062877
- **Lead sponsor:** Ge Zheng
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2021-12-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04062877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04062877, "Clinical Application of Liquid Biopsy for Precise Diagnosis and Prognosis in Lymphoma". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT04062877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*